SCOTT BIZILY plan to sell securities of 4D Molecular Therapeutics, Inc. under Form 144
2026-06-23SEC Filing 144 (0001950047-26-006432)
SCOTT BIZILY filed Form 144 to notify SEC of plan to sell 9810 units of 4D Molecular Therapeutics, Inc. securities around 2026-06-23, with aggregate market value of $102,220.20. The total outstanding units is 52276254.0. The amount planned to be sold represents 0.02% of total outstanding units;